Abstract
A Zn 2+ specific GdDOTA derivative containing two bis-(3-pyrazolyl) units was prepared and characterized. Unlike a previously reported Zn 2+ binding agent, the new agent binds to human albumin both in the presence and absence of Zn 2+.
Original language | English (US) |
---|---|
Pages (from-to) | 480-483 |
Number of pages | 4 |
Journal | MedChemComm |
Volume | 3 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2012 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry